Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Epizyme Inc (NQ: EPZM )

9.510 USD +0.310 (+3.37%)
Official Closing Price Updated: 7:54 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 907,200
Open 9.330
Bid (Size) 8.900 (1)
Ask (Size) 9.890 (2)
Prev. Close 9.200
Today's Range 8.980 - 9.540
52wk Range 8.940 - 22.68
Shares Outstanding 69,487,808
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Epizyme Outlines Clinical Progress, TAZVERIK Development Strategy and Pipeline Priorities During Company’s Strategic Vision Call
Epizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, hosted a call today outlining the Company’s strategic... 
From Business Wire News Releases
Epizyme to Host Strategic Vision Call on March 2, 2021
Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that it will host a call to discuss the... 
From Business Wire News Releases

Performance

YTD
-11.20%
-11.20%
1 Month
-17.09%
-17.09%
3 Month
-22.05%
-22.05%
6 Month
-24.94%
-24.94%
1 Year
-56.11%
-56.11%

More News

Read More
CORRECTING and REPLACING Epizyme Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
From Business Wire News Releases
Stocks That Hit 52-Week Lows On Wednesday
Tags Benzinga KPTI ATNX
From Benzinga
Epizyme Announces Date of Fourth Quarter and Full Year 2020 Financial Results and Participation in Upcoming Investor Conferences
From Business Wire News Releases
Stocks That Hit 52-Week Lows On Thursday
Tags News Markets Intraday Update
From Benzinga
Epizyme: Q4 Earnings Insights
Tags Market News News Benzinga
From Benzinga
Epizyme Inc (EPZM) Q4 2020 Earnings Call Transcript
Tags EPZM Market News
From Motley Fool
XBI's Underlying Holdings Could Mean 24% Gain Potential
Tags ETFs
From ETF Channel
Pharma Stock Ideas: Why BMO Is Recommending Regeneron, Constellation
Tags Benzinga BMO Capital Markets REGN
From Benzinga
Implied VHT Analyst Target Price: $244
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.